192 related articles for article (PubMed ID: 11153670)
1. Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection.
Fichtenbaum CJ; Zackin R; Feinberg J; Benson C; Griffiths JK;
AIDS; 2000 Dec; 14(18):2889-93. PubMed ID: 11153670
[TBL] [Abstract][Full Text] [Related]
2. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
Uthman MM; Uthman OA; Yahaya I
Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339
[TBL] [Abstract][Full Text] [Related]
3. Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators.
Holmberg SD; Moorman AC; Von Bargen JC; Palella FJ; Loveless MO; Ward DJ; Navin TR
JAMA; 1998 Feb; 279(5):384-6. PubMed ID: 9459473
[TBL] [Abstract][Full Text] [Related]
4. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
Cohn DL
Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
[TBL] [Abstract][Full Text] [Related]
5. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease.
Hewitt RG; Papandonatos GD; Shelton MJ; Hsiao CB; Harmon BJ; Kaczmarek SR; Amsterdam D
AIDS; 1999 Jul; 13(11):1367-72. PubMed ID: 10449290
[TBL] [Abstract][Full Text] [Related]
6. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
[TBL] [Abstract][Full Text] [Related]
7. Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis.
Bayoumi AM; Redelmeier DA
AIDS; 1998 Aug; 12(12):1503-12. PubMed ID: 9727572
[TBL] [Abstract][Full Text] [Related]
8. Hold the big MAC.
Young A
Notes Undergr; 1996 Apr; (no 32):6. PubMed ID: 11363450
[TBL] [Abstract][Full Text] [Related]
9. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?
Yangco BG; Buchacz K; Baker R; Palella FJ; Armon C; Brooks JT;
AIDS Patient Care STDS; 2014 Jun; 28(6):280-3. PubMed ID: 24833016
[TBL] [Abstract][Full Text] [Related]
10. Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis.
Pozniak A; Nelson MR
Genitourin Med; 1996 Aug; 72(4):269-71. PubMed ID: 8976832
[No Abstract] [Full Text] [Related]
11. Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS.
Jordan WC
J Natl Med Assoc; 1996 Jul; 88(7):425-7. PubMed ID: 8764523
[TBL] [Abstract][Full Text] [Related]
12. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
Dautzenberg B
Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194
[TBL] [Abstract][Full Text] [Related]
13. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
[TBL] [Abstract][Full Text] [Related]
14. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
[TBL] [Abstract][Full Text] [Related]
15. Reply to 'Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis' by Holmberg and Moorman.
Fichtenbaum CJ; Zackin R; Feinberg J
AIDS; 2001 Sep; 15(13):1745. PubMed ID: 11546956
[No Abstract] [Full Text] [Related]
16. Clinical and bacteriologic impact of rifabutin prophylaxis for Mycobacterium avium complex infection in patients with human immunodeficiency virus infection.
Maslo C; Buré-Rossier A; Girard PM; Gholizadeh Y; Lebrette MG; Rozenbaum W
Clin Infect Dis; 1997 Mar; 24(3):344-9. PubMed ID: 9114183
[TBL] [Abstract][Full Text] [Related]
17. Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus.
Ostroff SM; Spiegel RA; Feinberg J; Benson CA; Horsburgh CR
Clin Infect Dis; 1995 Aug; 21 Suppl 1():S72-6. PubMed ID: 8547516
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
[TBL] [Abstract][Full Text] [Related]
20. Rifabutin for MAC questioned.
Posit Aware; 1995; ():6. PubMed ID: 11362571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
